The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF)--practical implications

Athol U Wells, Athol U Wells

Abstract

Idiopathic pulmonary fibrosis (IPF), the most prevalent idiopathic interstitial pneumonia, is associated with a poor prognosis. An accurate diagnosis of IPF is essential for optimal management. The recent ATS/ERS/JRS/ALAT recommendations on the diagnosis and management of IPF were developed from a systematic review of the published literature. High-resolution computed tomography (HRCT) scanning has a central role in the IPF diagnostic pathway with formal designation of criteria for an HRCT pattern of UIP. In the correct clinical context, a UIP pattern on HRCT is indicative of a definite diagnosis of IPF without the need for a surgical lung biopsy. However, although the 2011 ATS/ERS/JRS/ALAT statement is a major advance, the application of guideline recommendations by clinicians has identified limitations that need to be addressed in future statements. Key problems include: 1) the lack of management recommendations for the highly prevalent clinical scenarios of probable and possible IPF; 2) the ongoing confusion about the diagnostic role of bronchoalveolar lavage (reflecting ambiguity in the current recommendation); 3) HRCT misdiagnosis by less experienced radiologists, increasingly recognised as a major problem; and 4) the lack of integration of clinical data, including the treated course of disease, in the designation of the diagnostic likelihood of IPF.

References

    1. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165(2):277–304.
    1. Raghu G, Collard HR, Egan JJ. et al.ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824. doi: 10.1164/rccm.2009-040GL.
    1. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174:810–816. doi: 10.1164/rccm.200602-163OC.
    1. Bjoraker JA, Ryu JH, Edwin MK. et al.Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998;157(1):199–203. doi: 10.1164/ajrccm.157.1.9704130.
    1. American Thoracic Society. Am J Respir Crit Care Med. Vol. 161. American Thoracic Society (ATS), and the European Respiratory Society (ERS); 2000. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement; pp. 646–664.
    1. Sundaram B, Gross BH, Martinez FJ. et al.Accuracy of high-resolution CT in the diagnosis of diffuse lung disease: effect of predominance and distribution of findings. AJR Am J Roentgenol. 2008;191(4):1032–9. doi: 10.2214/AJR.07.3177.
    1. Flaherty KR, King TE Jr, Raghu G. et al.Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med. 2004;170:904–910. doi: 10.1164/rccm.200402-147OC.
    1. Flaherty KR, Andrei AC, King TE Jr. et al.Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med. 2007;175:1054–1060. doi: 10.1164/rccm.200606-833OC.
    1. Fell CD, Martinez FJ, Liu LX. et al.Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010;181:832–837. doi: 10.1164/rccm.200906-0959OC.
    1. Ohshimo S, Bonella F, Cui A. et al.Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009;179(11):1043–1047. doi: 10.1164/rccm.200808-1313OC.
    1. Bradley B, Branley HM, Egan JJ. et al.Interstitial lung disease guidelines: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63(Suppl 5):v1–58.
    1. Grenier P, Valeyre D, Cluzel P. et al.Chronic diffuse interstitial lung disease: diagnostic value of chest radiography and high-resolution CT. Radiology. 1991;179:123–132.
    1. Tung KT, Wells AU, Rubens MB. et al.Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. Thorax. 1993;48:334–338. doi: 10.1136/thx.48.4.334.
    1. Lynch DA, Newell JD, Logan PM. et al.Can CT distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis? Am J Roentgenol. 1995;165:807–811. doi: 10.2214/ajr.165.4.7676971.
    1. Swensen S, Aughenbaugh G, Myers J. Diffuse lung disease: diagnostic accuracy of CT in patients undergoing surgical biopsy of the lung. Radiology. 1997;205:229–234.

Source: PubMed

3
Předplatit